| scholarly article | Q13442814 |
| P50 | author | Graham R. V. Hughes | Q73300356 |
| Ronald A. Asherson | Q73406057 | ||
| Eon Nigel Harris | Q73596049 | ||
| Azzudin E. Gharavi | Q73597624 | ||
| P2093 | author name string | Chan JK | |
| P2860 | cites work | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 |
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | Q33478061 | ||
| Thrombosis in patients with the lupus anticoagulant | Q33486691 | ||
| Recurrent venous thromboembolism in patients with a partial deficiency of protein S. | Q34251262 | ||
| Pulmonary hypertension in systemic lupus erythematosus. | Q34995801 | ||
| Antithrombin III in systemic lupus erythematosus | Q70518151 | ||
| Incidence of thromboembolism after stopping anticoagulant therapy. Relationship to hemorrhage at the time of termination | Q70568829 | ||
| Warfarin. From bedside to bench | Q70596709 | ||
| Recurring thrombo-embolic accidents caused by family-related deficiency of the fibrinolysis system | Q71528067 | ||
| Anticardiolipin antibodies and lupus anticoagulant | Q72593288 | ||
| The risk of interrupting long-term anticoagulant treatment. A rebound hypercoagulable state following hemorrhage | Q79420068 | ||
| Cerebral infarction in systemic lupus: association with anticardiolipin antibodies | Q93855660 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| antibody | Q79460 | ||
| (RS)-warfarin | Q407431 | ||
| P304 | page(s) | 823-825 | |
| P577 | publication date | 1985-12-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal | |
| P478 | volume | 44 |
| Q40807893 | A review of the hypercoagulable state. |
| Q44069797 | Anticardiolipin antibodies in patients with infectious diseases |
| Q53354829 | Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. |
| Q71984959 | Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis |
| Q35356556 | Antiphospholipid antibodies and cardiovascular disease |
| Q73086663 | Antiphospholipid antibodies and the antiphospholipid antibody syndrome |
| Q33491163 | Antiphospholipid antibodies in paediatrics |
| Q47221331 | Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study |
| Q40559210 | Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion |
| Q41442948 | Antiphospholipid antibody associated thrombosis: a consensus for treatment? |
| Q33328463 | Antiphospholipid antibody syndrome |
| Q33502495 | Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass |
| Q55462735 | Antiphospholipid antibody syndrome: a review. |
| Q41475138 | Cerebrovascular complications of rheumatic disease |
| Q40529762 | Clinical and therapeutic aspects of the antiphospholipid syndrome |
| Q68134484 | High aortic occlusion associated with lupus anti-coagulant |
| Q33379907 | Immunology and Clinical Importance of Antiphospholipid Antibodies |
| Q79157095 | In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome |
| Q69264400 | Inadequate periods of anticoagulation in the 'lupus anticoagulant syndrome'--a case report |
| Q33999868 | Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle |
| Q33613382 | Life-threatening right ventricular thrombosis in association with phospholipid antibodies |
| Q55476101 | Management of the antiphospholipid syndrome. |
| Q41197497 | Management of thrombosis in the antiphospholipid syndrome |
| Q36149928 | Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome |
| Q38211785 | Perioperative management of antiphospholipid antibody-positive patients |
| Q86527461 | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant |
| Q43446662 | Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications |
| Q33562467 | Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome |
| Q72897278 | Sneddon's syndrome and phospholipid antibodies |
| Q40971477 | Stroke is an emergency |
| Q33559469 | Superior mesenteric artery thrombosis associated with antiphospholipid syndrome. |
| Q40409582 | Superior mesenteric artery thrombosis in a patient with the antiphospholipid syndrome |
| Q33393937 | The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. |
| Q39195788 | The anti-phospholipid antibody syndrome in a 77 year old man with digital gangrene |
| Q40977408 | The antiphospholipid-protein syndrome |
| Q34824755 | The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies |
| Q71992286 | Treatment of the antiphospholipid syndrome |
| Q35702083 | Vascular disease, thrombosis, and recurrent abortion |
| Q44583525 | Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). |
Search more.